Dalhousie researcher receives $123,773 NSRIT award
Dalhousie's Daniel Boyd is the recipient of a $123,773 from the Nova Scotia Research and Innovation Trust.
This funding from NSRIT will go towards Dr. Boyd's total $330,964 project to purchase equipment to build capacity for innovative medical devices used in oncology and orthopaedics.
The funding for Dr. Boyd's research is part of a $2.63 million provincial investment that will put leading-edge research labs and equipment in place to support world-class research throughout the province.
NSRIT matches funding from the Canada Foundation for Innovation (CFI). Along with other partner contributions, including Genome Canada, this recent $2.63M investment represents a total value to the Province of Nova Scotia of $11M, through significant leveraging opportunities. It is predicted that upwards of 300 highly qualified people will be involved in these 17 research infrastructure projects over the next five years.
"These devices have major benefits for Nova Scotians. They are minimally invasive procedures, and reduce the need for long hospital stays. We’ve already had massive success. Worldwide, 40% of women over the age of 35 who develop uterine tumours may require a hysterectomy. Our device, implanted in the uterus, treats the fibroid tumour, drastically reducing the need for surgery.” - Dr. Daniel Boyd
"It’s a great investment that can bring economic, health, education and social benefits. NSRIT funding enables state-of-the-art research capacity to innovate and develop new products for today and tomorrow’s solutions. Students, and in fact all Nova Scotians, can reap positive outcomes for cutting-edge training, good jobs, and improved quality of living.” - Lois Levine, Executive Director, Nova Scotia Research and Innovation Trust
|Dr. Daniel Boyd|
- Charles Crosby, APR, Senior Advisor, Media, 902.494.1269, email@example.com